FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in the Execution of the Genesis Plan
Press Release FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in…
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK,…
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
January 13, 2026 07:05 ET | Source: Treace Medical Concepts, Inc. PONTE…
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
January 11, 2026 09:30 ET | Source: RxSight, Inc. ALISO VIEJO, Calif.,…
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
October 27, 2025 16:05 ET | Source: Pulmonx Corporation Glen French, member…
PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”…
Smart Share Global Limited Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company from Hillhouse
August 15, 2025 16:15 ET | Source: Smart Share Global Limited SHANGHAI,…
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium…
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
